논문 목록
9건 · 최신순-
Management of Complications Following Botulinum Toxin Facial Injections: A Narrative Review.
Botulinum toxin (BoNT) is widely used in the management of neurological disorders and in aesthetic medicine. Although generally safe, facial injections may be associated with complications with relevant functional or aesthetic impact. This …
-
Idiopathic Isolated Focal Jaw Tremor Responsive to Botulinum Toxin: A Case Report.
Jaw tremor is a form of orofacial tremor that can be seen as a symptom of various neurological disorders. Diagnosis and management are hindered when it presents without other neurological symptoms, and there is no consensus regarding the tr…
-
IncobotulinumtoxinA in refractory temporomandibular disorder due to disk dislocation: A prospective study.
[INTRODUCTION] Temporomandibular disorders (TMD) may include conditions involving the temporomandibular joint and/or masticatory muscles. Approximately 20 % of patients are refractory to first-line therapies. This study aims to evaluate the…
-
Botulinum Toxin Type A in Trigeminal Neuralgia Treatment: A Case Series and Literature Review.
Trigeminal neuralgia (TN) stands as a common neuropathic pain disorder. Clinically, it manifests with episodes characterized by unilateral electric shock-like or knife-like pain that can involve one or more divisions of the fifth cranial ne…
-
Shoulder Spasticity Treatment With Botulinum Toxin: A Nationwide Cross-Sectional Survey of Clinical Practices.
[INTRODUCTION] Upper limb spasticity can be responsible for several complications (e.g., pain, spasms, contractures, deformity, decreased or lost motor control), which can have a negative impact on functional independence and the quality of…
-
Botulinum toxin type A therapy for bilateral focal neuropathic pruritus in multiple sclerosis: a case report.
Neuropathic pruritus is a form of chronic itch that occurs in the presence of direct damage to the nervous system. It tends to be severe, disabling, and difficult to treat. Usual antipruritic medications are largely ineffective and there is…
-
Pain Reduction in Adults with Limb Spasticity Following Treatment with IncobotulinumtoxinA: A Pooled Analysis.
Some studies have shown that incobotulinumtoxinA reduces spasticity-associated pain, but further evidence is needed. This exploratory analysis pooled pain-relief data from six Phase 2 or 3 studies of incobotulinumtoxinA (four placebo-contro…
-
Contralateral Upper Limb Weakness Following Botulinum Toxin A Injection for Poststroke Spasticity.
Botulinum toxin type A has been approved for spasticity management in poststroke patients. The adverse effects are generally of two types: those related to local injection; and those related to the systemic effects from spread of the toxin.…
-
Correction to the article "Contralateral Upper Limb Weakness Following Botulinum Toxin A Injection for Poststroke Spasticity", published on Acta Med Port 2020 Nov;33(11):761-764.
On page 761, in the first sentence of the Introduction, where it reads: "Cardiovascular Botulinum toxin A (BoNT-A) has beenapproved for spasticity management."It should read: "Botulinum toxin A (BoNT-A) has been approved for spasticity mana…